CIPLA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CIPLA, and when can generic versions of CIPLA drugs launch?
CIPLA has ninety-one approved drugs.
There are six US patents protecting CIPLA drugs. There are thirty-three tentative approvals on CIPLA drugs.
There are thirty patent family members on CIPLA drugs in twenty-one countries and four hundred and thirty-nine supplementary protection certificates in seventeen countries.
Summary for CIPLA
| International Patents: | 30 |
| US Patents: | 6 |
| Tradenames: | 80 |
| Ingredients: | 80 |
| NDAs: | 91 |
| Patent Litigation for CIPLA: | See patent lawsuits for CIPLA |
| PTAB Cases with CIPLA as petitioner: | See PTAB cases with CIPLA as petitioner |
Drugs and US Patents for CIPLA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cipla Usa | ZEMDRI | plazomicin sulfate | SOLUTION;INTRAVENOUS | 210303-001 | Jun 25, 2018 | RX | Yes | Yes | 8,383,596 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Cipla | PREGABALIN | pregabalin | CAPSULE;ORAL | 212280-001 | Jan 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cipla | LAMIVUDINE | lamivudine | TABLET;ORAL | 077221-001 | Mar 3, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cipla | ARGATROBAN IN SODIUM CHLORIDE | argatroban | INJECTABLE;INTRAVENOUS | 022434-001 | Jun 29, 2011 | DISCN | Yes | No | 7,589,106 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Cipla | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077904-004 | Mar 22, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Cipla | ACYCLOVIR | acyclovir | OINTMENT;TOPICAL | 211794-001 | Jan 18, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CIPLA Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Slovenia | 2217610 | ⤷ Sign Up |
| Eurasian Patent Organization | 017824 | ⤷ Sign Up |
| Denmark | 2217610 | ⤷ Sign Up |
| Hungary | E030523 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2008045410 | ⤷ Sign Up |
| Australia | 2008326297 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for CIPLA Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1632232 | 122016000110 | Germany | ⤷ Sign Up | PRODUCT NAME: KOMBINATION VON RILPIVIRINHYDROCHLORID ODER EINER THERAPEUTISCH AEQUIVALENTEN, DURCH DAS GRUNDPATENT GESCHUETZTEN FORM DAVON UND TENOFOVIRALAFENAMID ODER EINEM PHARMAZEUTISCH AKZEPTABLEN SALZ DAVON, INSBESONDERE TENOFOVIRALAFENAMIDFUMARAT; REGISTRATION NO/DATE: EU/1/16/1112 20160621 |
| 0480717 | 9890027-7 | Sweden | ⤷ Sign Up | PRODUCT NAME: MONTELUKAST, R-(E)-1-1-3-2-(7-KLOR-2KINOLINYL)-ETENYL)-FENYL)-3-(2-(1-HYDROXI-1-METYLETYL)-FENYL)-PROPYL)-TIO)METYL)-CYKLOPROPANAETTIKSYRA, ELLER ETT FARMACEUTISKT GODDTAGBART SALT DAERAV, FOERETRAEDESVIS NATRIUMSALTET; NAT REG./DATE: 13944 19880111; FIRST REG.: FI EG 12766 19970825 |
| 0145340 | 99C0005 | Belgium | ⤷ Sign Up | PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204 |
| 0915894 | 08C0020 | France | ⤷ Sign Up | PRODUCT NAME: EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE; REGISTRATION NO/DATE: EU/1/07/430/001 20071213 |
| 2487163 | 60/2016 | Austria | ⤷ Sign Up | PRODUCT NAME: COBICISTAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON UND ATAZANAVIR ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE ATAZANAVIR-SULFAT; REGISTRATION NO/DATE: EU/1/15/1025 (MITTEILUNG) 20150715 |
| 0370453 | C300359 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ICATIBANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, BIJ VOORKEUR ICATIBANTACETAAT; REGISTRATION NO/DATE: EU/1/048/461/001 20080711 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
